Investment analysts at StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the stock. Several other brokerages also recently weighed in on MBRX. Maxim Group decreased their target price on Moleculin Biotech from $45.00 to $20.00 and set […]
Moleculin Biotech, Inc. (NASDAQ:MBRX) Forecasted to Earn FY2028 Earnings of $8.88 Per Share themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Moleculin Biotech, Inc. (NASDAQ:MBRX) to Post Q1 2024 Earnings of ($3.59) Per Share, Roth Capital Forecasts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Moleculin To Present At The Medinvest Biotech & Pharma Investor Conference menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.